Herpes Simplex Keratitis Treatment Market | GlaxoSmithKline, Vectans Pharma, Blistex, Bausch Health
By 2022, it is anticipated that the Herpes Simplex Keratitis Treatment Market would reach US$ 4.2 billion. Market size is estimated to reach US$ 7.9 billion in 2032 and grow at a robust CAGR of 6.1% between 2022 and 2032.One of the main causes of ocular morbidity worldwide, along with CMV retinitis in AIDS, is human...
Source: pharmiweb.com